CAEX
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
08/07/2026
Back to search
Official data from USPTO
VERAPTUS
This trademark appears in the official USPTO history.
Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9Type: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Case type
Application and registration
Recorded events
25
Latest update
08/07/2026
Trademark type
Word
Nice classes
5
Filing date
10/21/2014
Registration date
01/26/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/07/2026
Last transaction
08/07/2026
Responsible office
United States Patent and Trademark Office
Status code
710
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/28/2015
First use in commerce
09/28/2015
Drawing code
4
Owner type
01
Owner location
Tampa, FL, US
Examiner
HWANG, JOHN C B
Law office
M50
Current location
TMO LAW OFFICE 114
Holders and representatives
Holders
Donovan, Michael J.
Representatives
Donovan, Michael J.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Nucleic acid aptamers for medical diagnostic use; therapeutic nucleic acid aptamers for the treatment of infectious diseases; therapeutic nucleic acid aptamers for the treatment of cancer; pharmaceutical preparations for the treatment of viral infectious diseases; pharmaceutical preparations for the treatment of bacterial infectious diseases; pharmaceutical preparations for the treatment of cardiovascular disorders and conditions; pharmaceutical preparations for the treatment of respiratory disorders and conditions; pharmaceutical preparations for the treatment of fungal diseases and disorders; pharmaceutical preparations for the treatment of liver disease; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of HIV/AIDS and hepatitis
Publications
History of USPTO decisions and trademark events.
25 publications found
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/26/2025
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
06/22/2022
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
06/22/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/22/2022
ES8R
TEAS SECTION 8 RECEIVED
01/20/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/13/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/13/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/13/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/26/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
01/26/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/23/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/22/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/22/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/07/2015
IUAF
USE AMENDMENT FILED
11/15/2015
EISU
TEAS STATEMENT OF USE RECEIVED
11/15/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/19/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/24/2015
PUBO
PUBLISHED FOR OPPOSITION
03/24/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/04/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/11/2015
DOCK
ASSIGNED TO EXAMINER
02/09/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/28/2014
NWAP
NEW APPLICATION ENTERED
10/24/2014
Continuous trademark protection
Get notified about every new filing that threatens VERAPTUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.